1. The prognostic and predictive value of sstr2-immunohistochemistry and sstr2-targeted imaging in neuroendocrine tumors
2. Sharma, S., et al. (2009) Role of MGMT in Tumor Development, Progression, Diagnosis, Treatment and Prognosis. Anticancer Research, 29, 3759-3768.
3. Yang, Q.C., et al. (2014) Expression of O(6)-methylguanine DNA Methyltransferase (MGMT) and Its Clinical Significance in Gastroentero-pancreatic Neuroendocrine Neoplasm. International Journal of Clinical and Experimental Pathology, 7, 4204-4212.
4. O6-Methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: Enzyme activity, promoter methylation and immunohistochemistry
5. Temozolomide as Monotherapy Is Effective in Treatment of Advanced Malignant Neuroendocrine Tumors